TC Biopharm HoldingsTCBWFPreferred / convertible
13F holders, Q1 2024 (March 31)6holders
$0.02avg. 13F price*
At the end of Q1 2024, 6 institutions reported holding TC Biopharm Holdings Ltd. (TCBWF) in their 13F filings. The largest holders were Kepos Capital LP ($9K), Nantahala Capital Management, LLC ($5K) and Altium Capital Management LLC ($376).
- Company
- TC Biopharm Holdings Ltd.
- CUSIP
- 87807D111
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $358 |
Ownership 6 holders
| Kepos Capital LP | — | No change | 470,588 | $9K |
| Nantahala Capital Management, LLC | — | No change | 235,294 | $5K |
| Altium Capital Management LLC | — | No change | 18,823 | $376 |
| UBS Group AG | — | Reduce -92.0% | 1,094 | $22 |
| Bank of America Corp. | — | Add +10.0% | 582 | $12 |
| Virtu Financial LLC | — | Reduce -53.9% | 13,739 | $0 |
"% of holder's portfolio" is TCBWF's weight in each manager's 13F, not the share of TC Biopharm Holdings Ltd. the manager owns.